GIA
ZYNE

GHP Investment Advisors’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

GHP Investment Advisors’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1
Closed -$2 – 960
2023
Q3 		$2 Hold
1
– – ﹤0.01% 937
2023
Q2 		$1 Hold
1
– – ﹤0.01% 917
2023
Q1 		$1 Hold
1
– – ﹤0.01% 918
2022
Q4 		$1 Hold
1
– – ﹤0.01% 929
2022
Q3 		$0 Buy
+1
New +$1 ﹤0.01% 992

GHP Investment Advisors's ZYNE Position: Q4 2023 in Review

GHP Investment Advisors sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q4 2023, closing a stake of 1 share — an estimated $2 sold.

GHP Investment Advisors first reported a position in ZYNE in Q3 2022 and held it in 5 quarters. The position peaked at $2 in Q3 2023. 0 funds tracked by Wall St. Rank hold ZYNE as of Q4 2023.

  • GHP Investment Advisors reported no remaining Zynerba Pharmaceuticals, Inc position as of Q4 2023 after selling out during the quarter.
  • GHP Investment Advisors sold 1 Zynerba Pharmaceuticals, Inc share in Q4 2023, an estimated $2.
  • GHP Investment Advisors first reported a position in Zynerba Pharmaceuticals, Inc in Q3 2022 and held it in 5 quarters.
  • GHP Investment Advisors's Zynerba Pharmaceuticals, Inc position peaked at $2 in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2023.

Based on GHP Investment Advisors's 13F filing for Q4 2023, filed 26 Jan 2024.